Canadian Federal Court Deals Blow To Pfizer
In a departure from previous rulings, a Canadian federal court has shot down a patent protecting Norvasc, dealing a blow to Pfizer Inc. in its ongoing battle to shield the blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article